patent/EP-1489076-A4

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1489076-A4

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate	2003-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd6309c511f967f8ca4e664097dfe83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15b0aac75134ecf947746339e5f8121
publicationDate	2005-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-1489076-A4
titleOfInvention	CYCLIC HEMIACETAL DERIVATIVE AND USE THEREOF
abstract	A compound represented by the following general formula (I), which has calpain inhibitory activity: (I) wherein R1 represents lower alkyl; R2 represents hydrogen, halogeno, cyano, lower alkyl, or lower alkoxy; and n is 0 or 1.
priorityDate	2002-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0641800-A1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454973655 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27730 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID37232 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451

Total number of triples: 39.